Israel Englander’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$812K Sell
137,639
-1,370,424
-91% -$6.53M ﹤0.01% 4459
2026
Q1
$8.97M Buy
1,508,063
+475,383
+46% +$2.87M ﹤0.01% 2270
2025
Q4
$5.41M Buy
1,032,680
+442,980
+75% +$1.75M ﹤0.01% 2918
2025
Q3
$2.55M Sell
589,700
-199,609
-25% -$359K ﹤0.01% 3823
2025
Q2
$829K Buy
789,309
+485,736
+160% +$581K ﹤0.01% 4551
2025
Q1
$392K Sell
303,573
-397,705
-57% -$627K ﹤0.01% 4951
2024
Q4
$1.75M Buy
701,278
+657,420
+1,499% +$2.34M ﹤0.01% 3756
2024
Q3
$178K Buy
+43,858
New +$164K ﹤0.01% 5478
2023
Q1
Sell
-130,000
Closed -$1.33M 6949
2022
Q4
$1.33M Sell
130,000
-300,794
-70% -$3.05M ﹤0.01% 3895
2022
Q3
$4.33M Hold
430,794
﹤0.01% 3034
2022
Q2
$4.29M Buy
430,794
+117,700
+38% +$1.17M ﹤0.01% 2962
2022
Q1
$3.1M Buy
313,094
+183,094
+141% +$1.8M ﹤0.01% 3464
2021
Q4
$1.28M Buy
+130,000
New +$1.28M ﹤0.01% 4174

Other funds holding ZURA

Israel Englander's ZURA Position: Q2 2026 in Review

Israel Englander reduced its Zura Bio (ZURA) stake by 91% in Q2 2026, selling an estimated $6.53M and leaving 137,639 shares worth $812K. The position accounts for ﹤0.01% of the portfolio, ranked #4459.

Israel Englander first reported a position in ZURA in Q4 2021 and has held it in 13 quarters since. The position peaked at $8.97M in Q1 2026. 94 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Israel Englander held 137,639 shares of Zura Bio worth $812K as of Q2 2026.
  • Israel Englander sold 1,370,424 Zura Bio shares in Q2 2026, an estimated $6.53M.
  • Zura Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4459 holding.
  • Israel Englander first reported a position in Zura Bio in Q4 2021 and has held it in 13 quarters since.
  • Israel Englander's Zura Bio position peaked at $8.97M in Q1 2026.
  • 94 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.